Vicky Amidon Innovation Grant in Lung Cancer Research
The Vicky Amidon Innovation Grant offered by the Lung Cancer Initiative (LCI) supports exceptionally novel and creative research projects aimed at improving the lives of individuals diagnosed with lung cancer. Eligible research may be basic, translational, clinical, or epidemiological, with direct applicability to lung cancer. Projects should demonstrate innovative thinking and may focus on prevention, diagnosis, treatment, or survivorship.
Eligibility
-
Open to researchers of all levels at academic or community medical centers, CROs, emerging pharma, or other institutions.
-
Must be based in North Carolina or South Carolina.
-
Researchers from outside lung cancer research (e.g., other cancer or biomedical areas) are eligible if proposing novel approaches applicable to lung cancer.
-
Projects focused on lung cancer disparities or minority populations will receive favorable consideration.
-
Collaborative proposals are strongly encouraged.
Funding
-
Up to USD 25,000
-
One-year award term
Deadline
-
Application Deadline: August 29, 2025
-
Award Notification: October 17, 2025
-
Project Start Date: January 1, 2026
Further Information
-
Apply via ProposalCentral: Apply Here
-
Contact: Jenni Danai (Chief Mission Delivery Officer) at [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023